Patent: 7,846,687
✉ Email this page to a colleague
Summary for Patent: 7,846,687
Title: | Cytomegalovirus Intron A fragments |
Abstract: | Cytomegalovirus (CMV) Intron A fragments for expressing gene products are disclosed. Also described are expression vectors including the fragments, as well as methods of using the same. |
Inventor(s): | Thudium; Kent B. (Oakland, CA), Selby; Mark (San Francisco, CA) |
Assignee: | Novartis Vaccines & Diagnostics, Inc. (Emeryville, CA) |
Application Number: | 11/103,805 |
Patent Claims: | see list of patent claims |
Details for Patent 7,846,687
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2020-10-13 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2020-10-13 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2020-10-13 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |